Neovascularization of the iris (rubeosis iridis).
Gartner S, Henkind P.
Surv Ophthalmol. 1978 Mar-Apr;22(5):291-312. doi: 10.1016/0039-6257(78)90175-3.
Neovascular Glaucoma.
Mishra C, Meyer JJ.
2022 Nov 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis.
Locri F, Aronsson M, Beaujean O, Kvanta A, André H.
J Vis Exp. 2018 Mar 8;(133):57398. doi: 10.3791/57398.
Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report.
Modrzejewska M, Kulik U, Lubiński W.
Ginekol Pol. 2014 Jan;85(1):70-3. doi: 10.17772/gp/1695.
Neovascularization of the iris in retinoschisis.
Slean GR, Fu AD, Chen J, Kalevar A.
Am J Ophthalmol Case Rep. 2017 Jun 22;7:99-101. doi: 10.1016/j.ajoc.2017.06.019. eCollection 2017 Sep.
Experimental rubeosis of the iris in rabbits.
Kottow MH, DeLeon J.
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Dec 8;209(1):11-8. doi: 10.1007/BF00419158.
Retinoblastoma.
Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, Brisse H, Doz F, Desjardins L.
Orphanet J Rare Dis. 2006 Aug 25;1:31. doi: 10.1186/1750-1172-1-31.
Rubeosis of the iris in proliferative vitreoretinopathy.
van Meurs JC, Bolt BJ, Mertens DA, Peperkamp E, De Waard P.
Retina. 1996;16(4):292-5. doi: 10.1097/00006982-199616040-00003.
Etiology, pathogenesis, and diagnosis of neovascular glaucoma.
Călugăru D, Călugăru M.
Int J Ophthalmol. 2022 Jun 18;15(6):1005-1010. doi: 10.18240/ijo.2022.06.20. eCollection 2022.
Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.
Locri F, Pesce NA, Aronsson M, Cammalleri M, De Rosa M, Pavone V, Bagnoli P, Kvanta A, Dal Monte M, André H.
J Mol Med (Berl). 2020 Nov;98(11):1629-1638. doi: 10.1007/s00109-020-01979-8. Epub 2020 Sep 17.
